The ROE as of November 2024 (TTM) for Adamis Pharmaceuticals Corporation (ADMP) is 0.33%

According to Adamis Pharmaceuticals Corporation’s latest financial reports and current stock price. The company's current ROE is 0.33%. This represents a change of -99.73% compared to the average of 123.22% of the last 4 quarters.

Adamis Pharmaceuticals Corporation (ADMP) Historical ROE (quarterly & annually)

How has ADMP ROE performed in the past?

The mean historical ROE of Adamis Pharmaceuticals Corporation over the last ten years is 134.37%. The current 0.33% ROE has changed -99.75% with respect to the historical average. Over the past ten years (40 quarters), ADMP's ROE was at its highest in in the December 2022 quarter at 421.13%. The ROE was at its lowest in in the December 2020 quarter at -582.40%.

Adamis Pharmaceuticals Corporation (ADMP) ROE by Quarter and Year

Discovering the peaks and valleys of Adamis Pharmaceuticals Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Adamis Pharmaceuticals Corporation (ADMP) Average ROE

How has ADMP ROE performed in the past?

The current ROE of Adamis Pharmaceuticals Corporation (ADMP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Adamis Pharmaceuticals Corporation (ADMP) ROE vs. Peers

How is ADMP’s ROE compared to its peers?

Adamis Pharmaceuticals Corporation’s ROE is greater than Mallinckrodt plc (-74.45%), less than Lifecore Biomedical, Inc. (17.23%), greater than Lucy Scientific Discovery Inc. (-296.96%), greater than Alimera Sciences, Inc. (-33.70%), greater than Shuttle Pharmaceuticals Holdings, Inc. (-582.98%), greater than Organogenesis Holdings Inc. (-2.69%), greater than Catalent, Inc. (-11.44%), greater than Tilray Brands, Inc. (-6.23%), less than Aquestive Therapeutics, Inc. (0%), less than Evoke Pharma, Inc. (62.93%), greater than Guardion Health Sciences, Inc. (-308.51%), less than AcelRx Pharmaceuticals, Inc. (77.24%), greater than null (-39.88%),

Build a custom stock screener for Adamis Pharmaceuticals Corporation (ADMP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adamis Pharmaceuticals Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Adamis Pharmaceuticals Corporation (ADMP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Adamis Pharmaceuticals Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.